Optomed Oyj
HEL:OPTOMED.HE
3.16 (EUR) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5.099 | 3.109 | 3.505 | 3.327 | 3.66 | 4.218 | 3.744 | 3.478 | 4.013 | 3.7 | 3.733 | 3.214 | 3.552 | 3.342 | 4.012 | 3.944 | 4.041 | 3.338 | 2.597 | 3.034 | 4.329 | 3.551 | 3.858 | 3.24 | 4.688 | 3.362 |
| Cost of Revenue
| 1.778 | 1.417 | 1.064 | 3.784 | 1.192 | 1.371 | 1.292 | 1.002 | 1.227 | 1.576 | 1.584 | 1.061 | 1.201 | 1.14 | 1.311 | 1.449 | 1.272 | 1.105 | 0.777 | 1.059 | 1.595 | 1.281 | 1.4 | 1.01 | 1.579 | 1.424 |
| Gross Profit
| 3.321 | 1.692 | 2.441 | -0.457 | 2.468 | 2.847 | 2.452 | 2.476 | 2.786 | 2.124 | 2.149 | 2.153 | 2.351 | 2.202 | 2.701 | 2.495 | 2.769 | 2.233 | 1.82 | 1.975 | 2.734 | 2.27 | 2.458 | 2.23 | 3.109 | 1.938 |
| Gross Profit Ratio
| 0.651 | 0.544 | 0.696 | -0.137 | 0.674 | 0.675 | 0.655 | 0.712 | 0.694 | 0.574 | 0.576 | 0.67 | 0.662 | 0.659 | 0.673 | 0.633 | 0.685 | 0.669 | 0.701 | 0.651 | 0.632 | 0.639 | 0.637 | 0.688 | 0.663 | 0.576 |
| Reseach & Development Expenses
| 0.105 | 0.061 | 0.052 | 0.079 | 0.043 | 0.054 | 0.043 | 0.446 | 0.062 | 0.036 | 0.082 | 0.585 | 0.54 | 0.465 | 0.651 | 0.628 | 1.612 | 0.279 | 0.369 | 0.515 | 1.493 | 0.421 | 0.48 | 0.364 | 1.32 | 0 |
| General & Administrative Expenses
| 1.151 | 0.308 | 1.18 | 0.561 | 0.576 | 0.849 | 0.523 | 0.562 | 0.464 | 0.503 | 0.551 | 0 | 0.691 | 0 | 0 | 0 | 2.161 | 0 | 0 | 0 | 2.143 | 0 | 0 | 0 | 1.825 | 0 |
| Selling & Marketing Expenses
| 0.247 | 0.153 | 0.213 | 0.095 | 0.185 | 0.111 | 0.192 | 0.147 | 0.206 | 0.2 | 0.204 | 0 | 0.674 | 0 | 0 | 0 | 0.422 | 0 | 0 | 0 | 0.489 | 0 | 0 | 0 | 0.509 | 0 |
| SG&A
| 1.398 | 0.461 | 1.393 | 0.656 | 0.761 | 0.96 | 0.715 | 0.635 | 0.67 | 0.703 | 0.755 | 0.675 | 1.365 | 0.659 | 0.729 | 0.744 | 2.583 | 1.484 | 1.758 | 1.916 | 2.632 | 1.591 | 1.824 | 1.741 | 2.334 | 1.239 |
| Other Expenses
| 3.315 | 2.57 | 2.865 | 0 | 0.021 | -0.006 | 0.034 | 3.519 | 2.923 | 2.798 | 2.666 | 3.615 | 0.057 | 3.09 | 3.559 | 3.346 | 3.364 | 2.511 | 2.793 | 3.036 | 2.767 | 3.379 | 3.247 | 2.893 | 2.658 | 2.275 |
| Operating Expenses
| 4.818 | 3.092 | 1.445 | 0.735 | 3.786 | 3.45 | 3.461 | 3.519 | 3.655 | 3.537 | 3.503 | 3.615 | 4.531 | 3.09 | 3.559 | 3.346 | 3.364 | 2.511 | 2.793 | 3.036 | 2.767 | 3.379 | 3.247 | 2.893 | 2.658 | 2.275 |
| Operating Income
| -1.497 | -1.4 | -1.869 | -1.192 | -1.319 | -0.603 | -1.009 | -1.043 | -0.869 | -1.267 | -1.354 | -1.462 | -2.182 | -0.888 | -0.859 | -0.851 | -0.594 | -0.278 | -0.973 | -1.061 | -0.033 | -1.109 | -0.789 | -0.664 | 0.453 | -0.337 |
| Operating Income Ratio
| -0.294 | -0.45 | -0.533 | -0.358 | -0.36 | -0.143 | -0.269 | -0.3 | -0.217 | -0.342 | -0.363 | -0.455 | -0.614 | -0.266 | -0.214 | -0.216 | -0.147 | -0.083 | -0.375 | -0.35 | -0.008 | -0.312 | -0.205 | -0.205 | 0.097 | -0.1 |
| Total Other Income Expenses Net
| 0.493 | -0.198 | 0.053 | 0.094 | -0.231 | 0.144 | -0.325 | -0.134 | -0.547 | 0.014 | 0.007 | 0.072 | 0.226 | 0.035 | -0.025 | 0.216 | -0.069 | -0.041 | -0.023 | -0.209 | -0.068 | -0.142 | -0.217 | 0.07 | -0.102 | -0.102 |
| Income Before Tax
| -1.004 | -1.598 | -1.816 | -1.098 | -1.55 | -0.459 | -1.334 | -1.177 | -1.417 | -1.397 | -1.348 | -1.39 | -1.956 | -0.853 | -0.884 | -0.635 | -0.663 | -0.432 | -0.996 | -1.27 | -0.101 | -1.251 | -1.006 | -0.594 | 0.351 | -0.439 |
| Income Before Tax Ratio
| -0.197 | -0.514 | -0.518 | -0.33 | -0.423 | -0.109 | -0.356 | -0.338 | -0.353 | -0.378 | -0.361 | -0.432 | -0.551 | -0.255 | -0.22 | -0.161 | -0.164 | -0.129 | -0.384 | -0.419 | -0.023 | -0.352 | -0.261 | -0.183 | 0.075 | -0.131 |
| Income Tax Expense
| -0.015 | -0.021 | -0.023 | -0.007 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.019 | -0.011 | -0.02 | -0.02 | -0.02 | -0.042 | 0.004 | -0.019 | -0.019 | -0.098 | 0.036 |
| Net Income
| -0.989 | -1.577 | -1.793 | -1.09 | -1.53 | -0.439 | -1.314 | -1.157 | -1.397 | -1.377 | -1.328 | -1.37 | -1.936 | -0.833 | -0.864 | -0.616 | -0.652 | -0.412 | -0.976 | -1.25 | -0.058 | -1.256 | -0.987 | -0.575 | 0.449 | -0.476 |
| Net Income Ratio
| -0.194 | -0.507 | -0.512 | -0.328 | -0.418 | -0.104 | -0.351 | -0.333 | -0.348 | -0.372 | -0.356 | -0.426 | -0.545 | -0.249 | -0.215 | -0.156 | -0.161 | -0.123 | -0.376 | -0.412 | -0.013 | -0.354 | -0.256 | -0.177 | 0.096 | -0.142 |
| EPS
| -0.053 | -0.087 | -0.1 | -0.064 | -0.092 | -0.027 | -0.084 | -0.076 | -0.095 | -0.097 | -0.096 | -0.1 | -0.14 | -0.062 | -0.065 | -0.046 | -0.049 | -0.032 | -0.083 | -0.12 | -0.007 | -0.095 | -0.075 | -0.044 | 0.06 | -0.036 |
| EPS Diluted
| -0.053 | -0.087 | -0.1 | -0.064 | -0.092 | -0.027 | -0.084 | -0.076 | -0.095 | -0.097 | -0.096 | -0.1 | -0.14 | -0.062 | -0.065 | -0.046 | -0.049 | -0.032 | -0.083 | -0.12 | -0.007 | -0.095 | -0.075 | -0.044 | 0.06 | -0.036 |
| EBITDA
| -0.053 | -0.713 | -1.037 | -0.437 | -0.7 | 0.268 | -0.424 | -0.445 | -0.341 | 0.289 | -0.511 | -0.822 | -1.262 | -0.249 | 0.28 | -0.076 | 0.135 | 0.331 | -0.246 | -0.501 | 0.59 | -0.546 | -0.225 | 0.03 | 0.982 | 0.155 |
| EBITDA Ratio
| -0.01 | -0.229 | -0.296 | -0.131 | -0.191 | 0.064 | -0.113 | -0.128 | -0.085 | 0.078 | -0.137 | -0.256 | -0.355 | -0.075 | 0.07 | -0.019 | 0.033 | 0.099 | -0.095 | -0.165 | 0.136 | -0.154 | -0.058 | 0.009 | 0.209 | 0.046 |